Purpose As per GLOBACON 2012, the incidence of cervical cancer is 22.9% with a mortality rate of 54.9% (http:// globocan.iarc.fr, 2010). As the disease affects relatively younger population, high fatality rate impacts family and society in a disastrous way. Cervical carcinoma has a relatively poor prognosis due to advanced stage at presentation. We retrospectively analysed the treated cases of carcinoma cervix to know the impact of various prognostic factors on survival and patterns of failure in our hospital. Methods All cases treated from 2010 to 2015 (total 920 pts) who completed curative treatment in a tertiary care hospital were analysed to evaluate overall survival, disease-free survival, factors impacting survival, patterns of failure, factors affecting failure, mortality, and treatment-related toxicity. OS and DFS were calculated with Kaplan–Meier method, and log-rank test was used to identify the difference between groups. Failure factors were correlated with logistic regression, and toxicity was expressed in percentage. Results Univariate and multivariate analyses were performed. Pre treatment staging, lymphadenopathy, imaging used for diagnosis, hemoglobin levels extent of vagina involved and during treatment usage of concurrent chemotherapy, dose of radiation used, development of neutropenia and aftercompletion of treatment type of response had shown signiﬁcant impact on DFS
Indian Journal of Gynecologic Oncology – Springer Journals
Published: Jan 31, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera